engleski

Diagnostics and transfusion of a patient with multiple alloantibodies (and an alloantibodiy to a high-frequency antigen) treated with allogeneic bone marrow transplantation

Antibodies to high-frequency antigens (HFAs) are a transfusion hazard, as compatible blood is often very difficult to obtain. Other clinically significant alloantibodies represent an additional transfusion risk. In patients treated with allogeneic bone marrow transplantation (BMT) recipient red cell alloantibodies may cause acute or delayed haemolysis of donor red blood cells (RBC) and contribute to morbidity and mortality.

multiple alloantibodies ; alloantibody to a hihg-frequency antigen, allogeneic bone marrow transplantation

nije evidentirano